The GLP-1 component of tirzepatide triggers the same types of side effects you already experienced and adapted to with semaglutide
It is important to understand the distinctions between them for your safety and peace of mind
to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity and adults with overweight in the presence of at least one weight-related comorbid condition Limitations of Use: Concomitant use of Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended Important Safety Information for Wegovy WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Step 8: Safely dispose of the pen and/or used needle Now that your semaglutide injection is done, its time to safely dispose of your materials to avoid accidentally pricking yourself or others
Low Risk of Low Blood Sugar: Unlike some other diabetes medications, Ozempic doesn't often cause dangerously low blood sugar levels, making it safer for many people
Navigating Sleep Regressions: What Parents Need to Know About Baby Sleep Changes
